Wound healing progress tracking through mobile devices

通过移动设备跟踪伤口愈合进度

基本信息

  • 批准号:
    9605561
  • 负责人:
  • 金额:
    $ 74.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary: We propose in this SBIR effort to develop a smartphone or tablet based app for caregivers to perform non-invasive and quantitative measurements of patients' chronic wounds especially on diabtetic foot ulcers either at care facilities or at patients' home. Since chronic wounds take months or even longer to heal, it is highly likely that more and more patients will be discharged early from the hospitals. To follow up with the wound healing progress, outpatients must routinely visit clinicians for a long period of time in order to have their wound healing progress assessed. In addition, current wound assessment methods mostly provide information with poor accuracy and are invasive. The lack of precise wound data makes it difficult for clinicians to track subtle wound changes, thus hindering the correct assessment of the treatment effectiveness. The proposed software technology will be the first reported to offer precise wound measurement as well as analysis capabilities on mobile platforms. It will provide great benefit to chronic wound patients by providing a low-cost, effective, and personalized care solution. With its unique framework and many advantages over existing methods, the proprietary technology can be easily applied to the benefit of diagnosis and treatment on other type of wounds and diseases such as burns, acute wounds, battle wounds, and tumor irradiation treatment. It also has substantial potential for improving access to emergency care in any remote regions. With the ability of diagnosis and treatment remotely, we expect that our technology will completely change the landscape of the multi-billion dollar wound care market. There are approximately 6.5 million patients in the U.S. suffering from chronic wounds such as diabetic foot ulcers and pressure ulcers, and approximately 140,000 patients hospitalized every year with new wounds. The burden of treating chronic wounds is also growing rapidly due to increasing health care costs, an aging population, and a sharp rise in the incidence of diabetes and obesity worldwide. It is claimed that an excess of $25 billion is spent annually on the treatment of chronic wounds. Undoubtedly, the development of a mobile platform based 3D wound assessment tool is significant and will provide a much needed solution.
项目总结: 在这项SBIR努力中,我们建议开发一款基于智能手机或平板电脑的应用程序,供照顾者使用 对患者的慢性创面,特别是糖尿病患者的创面进行非侵入性和定量测量 在护理机构或病人家中的足部溃疡。因为慢性伤口需要几个月甚至是 随着治愈时间的延长,极有可能会有越来越多的患者提前出院。 为了跟踪伤口愈合的进展,门诊患者必须定期长时间拜访临床医生。 以评估他们的伤口愈合进度。此外,目前的伤口评估 方法大多提供准确性差的信息,而且是侵入性的。缺乏准确的伤口数据 使临床医生难以跟踪伤口的细微变化,从而阻碍了对 观察治疗效果。拟议中的软件技术将是第一个报告提供精确的 移动平台上的伤口测量和分析功能。它将为……提供巨大的好处 为慢性创面患者提供低成本、高效和个性化的护理解决方案。以其独特的 框架和与现有方法相比的许多优点,专有技术可以很容易地 适用于烧伤等其他类型创伤和疾病的诊断和治疗, 急性创伤、战伤和肿瘤放射治疗。它还具有巨大的潜力 改善任何偏远地区获得紧急护理的机会。具有诊断和治疗能力 远程,我们预计我们的技术将彻底改变数十亿美元的格局 伤口护理市场。 在美国,大约有650万名患者患有慢性伤口,如 糖尿病足溃疡和压疮,每年约有140,000名患者因 新的伤口。由于健康状况的提高,治疗慢性伤口的负担也在迅速增加。 护理费用、人口老龄化,以及全球糖尿病和肥胖症发病率的急剧上升。它是 声称每年用于治疗慢性伤口的费用超过250亿美元。毫无疑问, 基于移动平台的3D创伤评估工具的开发具有重要意义,并将提供 亟需的解决方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Yi其他文献

Steven Yi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Yi', 18)}}的其他基金

A low cost and effective foot orthotics fabrication framework
低成本且有效的足部矫形器制造框架
  • 批准号:
    10624329
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
A low cost and effective foot orthotics fabrication framework
低成本且有效的足部矫形器制造框架
  • 批准号:
    10251746
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
A low cost and effective foot orthotics fabrication framework
低成本且有效的足部矫形器制造框架
  • 批准号:
    10609223
  • 财政年份:
    2021
  • 资助金额:
    $ 74.95万
  • 项目类别:
Wound management through quantitative documentation and prediction
通过定量记录和预测进行伤口管理
  • 批准号:
    10447880
  • 财政年份:
    2020
  • 资助金额:
    $ 74.95万
  • 项目类别:
Wound management through quantitative documentation and prediction
通过定量记录和预测进行伤口管理
  • 批准号:
    10469685
  • 财政年份:
    2020
  • 资助金额:
    $ 74.95万
  • 项目类别:
Wound management through quantitative documentation and prediction
通过定量记录和预测进行伤口管理
  • 批准号:
    10081799
  • 财政年份:
    2020
  • 资助金额:
    $ 74.95万
  • 项目类别:
A Low-Cost and Convenient Solution for Hearing Aid Shell Manufacturing
助听器外壳制造的低成本、便捷的解决方案
  • 批准号:
    9905577
  • 财政年份:
    2018
  • 资助金额:
    $ 74.95万
  • 项目类别:
Augmenting Endoscopic Instruments with Real-time 3D Imaging
通过实时 3D 成像增强内窥镜仪器
  • 批准号:
    9339459
  • 财政年份:
    2017
  • 资助金额:
    $ 74.95万
  • 项目类别:
Real-time 3D Imaging Guided ART
实时 3D 成像引导 ART
  • 批准号:
    8902326
  • 财政年份:
    2015
  • 资助金额:
    $ 74.95万
  • 项目类别:
An Intelligent Capsule Endoscopy Video Analysis Software Platform
智能胶囊内窥镜视频分析软件平台
  • 批准号:
    8195537
  • 财政年份:
    2011
  • 资助金额:
    $ 74.95万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 74.95万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了